Review links vitamin D and vitamin A immune signals to MS
By MS Buddy ·
Summarized from International immunopharmacology, Nov 2026 · PubMed. AI-generated summary. Not medical advice.
Review · research on MS and other allergic and autoimmune diseases
Research by Biswajit Biswas and Ritobrata Goswami at Indian Institute of Technology Kharagpur in India.
How are vitamin D and vitamin A signals linked to immune activity in MS?
Key Takeaway
A review links vitamin D and vitamin A signals to immune activity in MS and other inflammatory diseases.

What They Found
The review describes how cells use vitamin D and vitamin A signals to help control immune responses. It discusses how these signals affect immune cells and the barriers that protect body tissues. It links changes in these signals to MS and several other diseases involving the immune system. The authors also examine gene differences that may affect how the body responds to vitamin D. They discuss possible treatments based on these signals, but the abstract does not report treatment results.
Who Should Care and Why
This review covers research on MS, allergic asthma, and other diseases involving the immune system. It is relevant to people with MS because MS is one of the diseases discussed. The authors focus on how vitamin-related signals may shape immune activity. They also consider ideas for future treatments. The abstract does not say whether those treatments help people with MS.
Important Considerations
You are reading a review, not a new study of people with MS. The abstract gives no sample size or results from a treatment test. You cannot tell from this abstract whether changing vitamin D or vitamin A signals improves MS.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in International immunopharmacology by . Reproduced from the PubMed record.
Nuclear receptors (NRs) translate environmental and metabolic cues into transcriptional programs that calibrate immune responses. In the NR superfamily, the vitamin D receptor (VDR) and retinoic acid receptors (RARs) occupy distinctive position as vitamin-derived ligand sensors, signal as obligate heterodimers with the retinoid X receptor (RXR), and both shape T cell fate, mucosal tolerance, and epithelial barrier integrity. Dysregulation of either pathway has been mechanistically linked toward varying degree of pathophysiology of allergic asthma, inflammatory bowel disease (IBD), multiple sclerosis (MS), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). This review synthesizes current understanding of how VDR and RAR signaling regulate effector and regulatory T cell programs, macrophage polarization, and epithelial homeostasis in allergic and autoimmune inflammation. We examine receptor-specific transcriptional mechanisms, the immunological consequences of common VDR polymorphisms, and the therapeutic landscape spanning calcitriol analogues, non-secosteroidal VDR modulators, and retinoic acid-based interventions. We also highlight points of convergence between VDR and RAR signaling that suggest combinatorial therapeutic potential. By integrating mechanistic, genetic, and translational evidence, we propose that VDR and RAR function as nutrient-sensing immune integrators whose pharmacological modulation offers a precision route to recalibrating inflammatory diseases.
Categories
Explore more research
Related MS research

11/20/2026
A review looks at changes in how the body uses tryptophan (a building block of proteins) in MS and o
Read More
11/19/2026
Five people with MS received engineered immune cells. Spinal fluid immune changes were seen, but saf
Read More
11/20/2026
A small study followed brain connections and thinking in early MS over 10 months. Patterns differed
Read More
11/20/2026
A global study including childhood MS found rising rates and disability from rare childhood brain an
Read More
11/20/2026
Removing a protein that restrains immune cells worsened MS-like disease in mice. This laboratory stu
Read More
11/20/2026
Researchers identified disease-driving immune cells in an MS model and related human diseases. Lab f
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
